Related
Rett Syndrome Research Trust Partners with Vivalink to Accelerate Research
Rare Daily Staff Digital health technology provider Vivalink entered into a collaboration with the Rett Syndrome Research […]
Read moreLabcorp to Acquire Invitae Assets
Rare Daily Staff Laboratory services company Labcorp said it’s $239 million bid for assets of the medical […]
Read moreAddressing a Shortage of Genetic Counselors with AI
As genetic testing continues to expand, it is bringing into focus a shortage of genetic counselors who […]
Read moreEndeavor Bio Raises $132.5 Million to Advance Pipeline
Rare Daily Staff Endeavor BioMedicines raised $132.5 million in a series C financing, including the conversion of […]
Read moreFDA Grants Accelerated Approval to Day One’s Ojemda for Childhood Brain Tumor
Rare Daily Staff The U.S. Food and Drug Administration has granted accelerated approval to Day One Biopharmaceuticals’ […]
Read moreProfluent Releases AI-Created and Open-Source Gene Editor
Rare Daily Staff Profluent said it demonstrated the first successful precision editing of the human genome with […]
Read moreEC Grants Accelerated Approval to Travere and CSL Vifor’s Filspari for Rare Kidney Disease
Rare Daily Staff The European Commission granted accelerated approval to Travere Therapeutics and CSL Vifor’s Filspari for […]
Read moreFDA Approves Novartis’ Lutathera for Children with Rare Neuroendocrine Tumors
Rare Daily Staff The U.S. Food and Drug Administration approved Novartis’ radioligand therapy Lutathera for the treatment […]
Read moreSeamless Raises $25 Million in Seed Financing, Expands to U.S. to Advance Programmable Gene Editing Platform
Rare Daily Staff German biotech Seamless Therapeutics closed a $25 million in seed financing to support the […]
Read more